These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6593323)

  • 1. Primary structure of human class II histocompatibility antigens. Reversed-phase high-performance liquid chromatography for integral membrane proteins.
    Kratzin HD; Kruse T; Maywald F; Thinnes FP; Götz H; Egert G; Pauly E; Friedrich J; Yang CY; Wernet P
    J Chromatogr; 1984 Aug; 297():1-11. PubMed ID: 6593323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).
    Götz H; Kratzin H; Thinnes FP; Yang C; Kruse T; Pauly E; Kölbel S; Egert G; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):749-55. PubMed ID: 6576979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens.
    Walker LE; Hewick R; Hunkapiller MW; Hood LE; Dreyer WJ; Reisfeld RA
    Biochemistry; 1983 Jan; 22(1):185-8. PubMed ID: 6600932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial amino acid sequence of papain-solubilized class II transplantation antigens.
    Wiman K; Claesson L; Rask L; Trägårdh L; Peterson PA
    Biochemistry; 1982 Oct; 21(21):5351-8. PubMed ID: 6816270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].
    Kratzin H; Yang CY; Götz H; Pauly E; Kölbel S; Egert G; Thinnes FP; Wernet P; Altevogt P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1665-9. PubMed ID: 6947956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and evolutionary analysis of HLA-D-region products.
    Travers P; Blundell TL; Sternberg MJ; Bodmer WF
    Nature; 1984 Jul 19-25; 310(5974):235-8. PubMed ID: 6379465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain].
    Egert G; Thinnes FP; Götz H; Pauly E; Kratzin H; Yang CY; Kölbel S; Altevogt P; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1291-308. PubMed ID: 6334639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and purification of HLA-DR antigens from tumour cells by affinity chromatography and chromatofocusing.
    Bernard D; Maurizis JC; Chollet P; Chassagne J; Plagne R
    J Chromatogr; 1984 Jun; 308():322-8. PubMed ID: 6589234
    [No Abstract]   [Full Text] [Related]  

  • 12. Microsequence analysis of peptides and proteins. III. Artifacts and the effects of impurities on analysis.
    Shively JE; Hawke D; Jones BN
    Anal Biochem; 1982 Mar; 120(2):312-2. PubMed ID: 6178317
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets.
    Lippolis JD; White FM; Marto JA; Luckey CJ; Bullock TN; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 2002 Nov; 169(9):5089-97. PubMed ID: 12391225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary structure of class II human histocompatibility antigens. 2nd Communication. Amino acid sequence of the N-terminal 179 residues of the alpha-chain of an HLA-Dw2/DR2 alloantigen (author's transl)].
    Yang C; Kratzin H; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):671-6. PubMed ID: 6955253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative dot immunobinding assay for human HLA class II antigens using nitrocellulose membrane filters.
    Teyton L; Lotteau V; Boyer B; Charron DJ
    J Immunol Methods; 1986 May; 89(1):73-9. PubMed ID: 3517174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hb-Linköping (beta 36 Pro----Thr): a new hemoglobin mutant characterized by reversed-phase high-performance liquid chromatography.
    Jeppsson JO; Källman I; Lindgren G; Fägerstam LG
    J Chromatogr; 1984 Aug; 297():31-6. PubMed ID: 6548480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
    Newcomb JR; Cresswell P
    J Immunol; 1993 Jan; 150(2):499-507. PubMed ID: 8419482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial N-terminal sequence analysis of DRw53 antigens: the beta-chains of DRw53 antigens are structurally distinct from beta-chains of DR and DQ antigens.
    Obata F; Endo T; Tate G; Miyokawa N; Katagiri M; Kashiwagi N
    J Immunol; 1986 Mar; 136(6):2187-90. PubMed ID: 3456389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high yield purification procedure for alpha and beta chains of HLA-DR antigens.
    Walker LE; Reisfeld RA
    J Biol Chem; 1982 Jul; 257(14):7940-3. PubMed ID: 6979540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci.
    Wu S; Saunders TL; Bach FH
    Nature; 1986 Dec 18-31; 324(6098):676-9. PubMed ID: 3099214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.